Thailand has introduced two new categories to the list of prohibited cosmetic advertising claims under the Cosmetic Act B.E. 2558 (2015) to address misleading and unethical practices.
Under the Cosmetic Act B.E. 2558 (2015), Thailand prohibits cosmetics advertising that contains statements intended to deceive consumers or may have negative effects on society at large. This can include all statements regarding a product’s place of origin, condition, quality, quantity, or properties. Specifically, the following types of claims are prohibited:
We provide full-scale global cosmetic market entry services (including cosmetic registering & filing, regulatory consultation, customized training, market research, branding strategy). Please contact us to discuss how we can help you by cosmetic@chemlinked.com
Thailand Publishes a List of Claims Allowed in the Labels and Advertisements of Cannabis Cosmetics
China Underscores Importance of Cosmetic Labeling Claims and Advertising Compliance Requirements
China Cosmetic Compliance Strategy: A Collection of Prohibited Claims on Cosmetic Packaging and Advertisements
Chemlinked team summarizes and analyzes non-compliance cases and their causes in cosmetic industry worldwide. By examining these real-world cases, we aim to provide warnings to cosmetics companies and encourage them to improve their product quality, thereby ensuring consumer safety and promoting sustainable development of the beauty industry.
Under the current regulatory framework, cosmetics registrants and notifiers can continue to submit a simplified version of the safety assessment report during the registration or notification process until May 1, 2025. Following this deadline, a full version of the safety assessment will be mandated. To facilitate a smooth transition, China is planning to release a set of technical guidelines.
Since the implementation of the Cosmetic Supervision and Administration Regulation (CSAR) in 2021, China has adopted a classified management approach for new cosmetic ingredients (NCIs) based on their risk levels. High-risk NCIs require registration, while low- and medium-risk NCIs can be notified through online dossier submissions, streamlining market entry. China is continually issuing new regulations and guidelines to clarify the requirements for NCI registration and notification.
Request a Demo